Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Research and Development Tax Credit Act of 2007
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
Research and Development Tax Credit Act of 2007
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALLERGAN, INC. via ALLERGAN, INC.
2009 · second_quarter · Q2
BILL NOT YET ASSIGNED: FOOD & DRUG ADMINISTRATION MATTERS BILL NOT YET ASSIGNED: FOLLOW-UP ON BIOLOGICALS LEGISLATION
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2009 · first_quarter · 1A
Source: Senate LDA
Research and Development Tax Credit Act of 2007
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILARS ACT; PROVISIONS OF FOLLOW-ON BIOLOGICALS
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILARS ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
HR5629: PATHWAY FOR BIOSIMILARS ACT; PROVISIONS OF FOLLOW-ON BIOLOGICALS
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILARS ACT.; PROVISIONS ON FOLLOW-ON BIOLOGICALS
HR5629: PATHWAY FOR BIOSIMILARS ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILARS ACT.; PROVISIONS ON FOLLOW-ON BIOLOGICALS
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
Renewable Energy and Job Creation Tax Act of 2008
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR6049: ENERGY IMPROVEMENT AND EXTENSION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT HR7060: RENEWABLE ENERGY AND JOB CREATION TAX ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT S3335: JOBS, ENERGY, FAMILIES, AND DISASTER RELIEF ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
Renewable Energy and Job Creation Tax Act of 2008
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR6049: ENERGY IMPROVEMENT AND EXTENSION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT HR7060: RENEWABLE ENERGY AND JOB CREATION TAX ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT S3335: JOBS, ENERGY, FAMILIES, AND DISASTER RELIEF ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
Jobs, Energy, Families, and Disaster Relief Act of 2008
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR6049: ENERGY IMPROVEMENT AND EXTENSION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT HR7060: RENEWABLE ENERGY AND JOB CREATION TAX ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT S3335: JOBS, ENERGY, FAMILIES, AND DISASTER RELIEF ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
Jobs, Energy, Families, and Disaster Relief Act of 2008
Client: ALLERGAN, INC. · Firm: ALLERGAN, INC.
HR6049: ENERGY IMPROVEMENT AND EXTENSION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT HR7060: RENEWABLE ENERGY AND JOB CREATION TAX ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT S3335: JOBS, ENERGY, FAMILIES, AND DISASTER RELIEF ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
BILL NOT YET ASSIGNED: EYE CARE PRODUCTS ISSUES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2009 · first_quarter · Q1
BILL NOT YET ASSIGNED: EYE CARE PRODUCTS ISSUES
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2008 · fourth_quarter · 4A
HR5629: PATHWAY FOR BIOSIMILARS ACT; PROVISIONS OF FOLLOW-ON BIOLOGICALS
HR1424: EMERGENCY ECONOMIC STABILIZATION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
Filing targets: HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
2008 · third_quarter · 3A
HR6049: ENERGY IMPROVEMENT AND EXTENSION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT HR7060: RENEWABLE ENERGY AND JOB CREATION TAX ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT S3335: JOBS, ENERGY, FAMILIES, AND DISASTER RELIEF ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
HR5629: PATHWAY FOR BIOSIMILARS ACT.; PROVISIONS ON FOLLOW-ON BIOLOGICALS
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2008 · second_quarter · 2A
HR6049: RENEWABLE ENERGY AND JOB CREATION ACT OF 2008; ALL ASPECTS OF THE BILL
HR5629: PATHWAY FOR BIOSIMILARS ACT; ALL ASPECTS OF BILL
Filing targets: HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
2008 · first_quarter · 1A
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
Filing targets: HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
2008 · fourth_quarter · Q4
HR5629: PATHWAY FOR BIOSIMILARS ACT; PROVISIONS OF FOLLOW-ON BIOLOGICALS
HR1424: EMERGENCY ECONOMIC STABILIZATION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
Filing targets: HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
2008 · third_quarter · Q3
HR5629: PATHWAY FOR BIOSIMILARS ACT.; PROVISIONS ON FOLLOW-ON BIOLOGICALS
HR6049: ENERGY IMPROVEMENT AND EXTENSION ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT HR7060: RENEWABLE ENERGY AND JOB CREATION TAX ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT S3335: JOBS, ENERGY, FAMILIES, AND DISASTER RELIEF ACT OF 2008; RESEARCH & DEVELOPMENT TAX CREDIT
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2008 · second_quarter · Q2
HR5629: PATHWAY FOR BIOSIMILARS ACT; ALL ASPECTS OF BILL
HR6049: RENEWABLE ENERGY AND JOB CREATION ACT OF 2008; ALL ASPECTS OF THE BILL
Filing targets: HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
2008 · first_quarter · 1A
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
Filing targets: HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
2008 · first_quarter · Q1
HR1712: RESEARCH AND DEVELOPMENT TAX CREDIT ACT OF 2007; ALL ASPECTS OF BILL HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF THE BILL
HR5629: PATHWAY FOR BIOSIMILAR ACT; ALL ASPECTS OF BILL
Filing targets: HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
2007 · year_end · YA
MEDICARE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2007 · year_end · YA
MEDICARE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2007 · year_end · YY
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2007 · mid_year · MM
Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2006 · year_end · YY
Medicare
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2006 · mid_year · MMY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2005 · year_end · YY
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2003 · year_end · YY
Medicare Reimbursement Reform
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2003 · mid_year · MM
Medicare Reimbursement Reform especially as relate to Hospital Outpatient Prospective Payment System
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2002 · mid_year · RA
MEDICARE, FOLLOW-ON BIOLOGICALS, RESEARCH AND DEVELOPMENT TAX CREDIT
MEDICARE, FOLLOW-ON BIOLOGICALS, RESEARCH AND DEVELOPMENT TAX CREDIT
MEDICARE, FOLLOW-ON BIOLOGICALS, RESEARCH AND DEVELOPMENT TAX CREDIT
ALLERGAN, INC. via ALLERGAN, INC.
2002 · year_end · YY
Medicare Reimbursement Prescription Drug Reforms especially as relate to Hospital Outpatient Prospective Payment System
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ALLERGAN, INC. via ALLERGAN, INC.
2002 · mid_year · MM
Medicare Prescription Drug Reforms as related to hospital outpatient issues
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS)
ALLERGAN, INC. via ALLERGAN, INC.
2000 · year_end · YA
Filing targets: Centers For Medicare and Medicaid Services (CMS)
ALLERGAN, INC. via ALLERGAN, INC.
1999 · year_end · YY
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES
ALLERGAN, INC. via ALLERGAN, INC.
1999 · mid_year · MM
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE